{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:15:58Z","timestamp":1794590158782,"version":"4.9.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1111\/j.1525-1438.2007.01043.x","type":"journal-article","created":{"date-parts":[[2007,8,11]],"date-time":"2007-08-11T02:19:53Z","timestamp":1186798793000},"page":"439-445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The use and understanding of CA125 as a tumor marker for ovarian cancer: a questionnaire-based survey"],"prefix":"10.1016","volume":"18","author":[{"given":"E.L.","family":"MOSS","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"HOLLINGWORTH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"HOLLAND","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"MURPHY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"FERNANDO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.M.","family":"REYNOLDS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0005","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJM198310133091503","article-title":"A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer","volume":"309","author":"Bast","year":"1983","journal-title":"NEJM"},{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/ajcp\/79.1.98","article-title":"Immuno- pathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types","volume":"79","author":"Kabawat","year":"1983","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0015","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/000456329803500402","article-title":"Clinical applications and assay requirements","volume":"35","author":"Sturgeon","year":"1998","journal-title":"Ann Clin Biochem"},{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0020","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/000456328402100401","article-title":"The value of carcinoembryonic antigen measurement in clinical practice","volume":"21","author":"Begent","year":"1984","journal-title":"Ann Clin Biochem"},{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/172460089801300402","article-title":"CA125: the past and the future","volume":"13","author":"Bast","year":"1998","journal-title":"Int J Biol Markers"},{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0030","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1054\/bjoc.2001.1787","article-title":"Serum tumour marker CA125 in monitoring of ovarian cancer during first-line chemotherapy","volume":"84","author":"Tuxen","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0035","first-page":"6335","article-title":"Recognition of ovarian cancer antigen CA125 by murine monoclonal antibody produced by immunization of lung cancer cells","volume":"47","author":"Matsuoka","year":"1987","journal-title":"Cancer Res"},{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0040","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1067\/mob.2003.304","article-title":"CA125 levels in the preoperative assessment of advanced uterine cancer","volume":"188","author":"Jhang","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0045","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/jso.20534","article-title":"CA125: a potential tumor marker for gallbladder cancer","volume":"93","author":"Chaube","year":"2006","journal-title":"J Surg Oncol"},{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0050","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1245\/ASO.2003.05.015","article-title":"Cancer antigen 125 associated with multiple benign and malignant pathologies","volume":"10","author":"Miralles","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0055","first-page":"341","article-title":"Pelvic inflammatory disease. Correlation of severity with CA125 levels","volume":"41","author":"Moley","year":"1996","journal-title":"J Reprod Med"},{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0060","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1471-0528.1990.tb02448.x","article-title":"A risk of malignancy index incorporating CA125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer","volume":"97","author":"Jacobs","year":"1990","journal-title":"B J Obstet Gynaecol"},{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0065","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1471-0528.1996.tb09882.x","article-title":"Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses","volume":"103","author":"Tingulstad","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0070","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1258\/000456303770367234","article-title":"Tumour markers: their use and misuse by clinicians","volume":"40","author":"McGinley","year":"2003","journal-title":"Ann Clin Biochem"},{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0075","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/jcp.2004.018077","article-title":"The role of CA125 in clinical practice","volume":"58","author":"Moss","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0080","series-title":"Practical nonparametric statistics","author":"Conover","year":"1980"},{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0085","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0895-4356(97)00126-1","article-title":"Response rates to mail surveys published in medical journals","volume":"50","author":"Asch","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0090","first-page":"36","article-title":"CA125 in ovarian cancer","volume":"40","author":"van der Burg","year":"1992","journal-title":"Neth J Med"},{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0095","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/bmj.313.7069.1355","article-title":"Risk of diagnosis of ovarian cancer after raised serum CA125 concentration: a prospective cohort study","volume":"313","author":"Jacobs","year":"1996","journal-title":"BMJ"},{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0100","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ygyno.2006.04.010","article-title":"Peritoneal tuberculosis mimicking advanced ovarian cancer: a retrospective review of 22 cases","volume":"103","author":"Koc","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0105","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/oxfordjournals.humrep.a019240","article-title":"Spontaneous ovarian hyperstimulation mimicking an ovarian tumour","volume":"11","author":"Lipitz","year":"1996","journal-title":"Human Reprod"},{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0110","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1634\/theoncologist.7-5-437","article-title":"CA125 response: can it replace the traditional response criteria in ovarian cancer?","volume":"7","author":"Guppy","year":"2002","journal-title":"Oncologist"},{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0115","unstructured":"Duffy M, McGing P, Mc Sweeny J. Guidelines for the use of tumour markers. Association of clinical biochemists in Ireland. Available at: http:\/\/www.iol.ie\/~deskenny\/acbi-tmk.html. 2000. [accessed July 2007]."},{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0120","unstructured":"MRC clinical trials unit. Available at: http:\/\/www.ctu.mrc.ac.uk\/ studies\/CHORUS.asp. [accessed July 2007]."},{"key":"10.1111\/j.1525-1438.2007.01043.x_bb0125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000010062","article-title":"Preoperative determination of several serum tumour markers in patients with primary epithelial ovarian cancer","volume":"47","author":"Kudoh","year":"1999","journal-title":"Gynecol Obstet Invest"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24153741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24153741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1111\/j.1525-1438.2007.01043.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:12:15Z","timestamp":1753233135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24153741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S1048891X24153741"],"URL":"https:\/\/doi.org\/10.1111\/j.1525-1438.2007.01043.x","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use and understanding of CA125 as a tumor marker for ovarian cancer: a questionnaire-based survey","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1525-1438.2007.01043.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2008 by IGCS and ESGO.","name":"copyright","label":"Copyright"}]}}